Neuropeptides 2001: Alzheimer's Disease Symposium

神经肽 2001：阿尔茨海默病研讨会

• 批准号: 6369330
• 负责人: KIM B SEROOGY
• 金额: $ 1.26万
• 依托单位: UNIVERSITY OF KENTUCKY
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-06-15 至 2002-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6369330
• 关键词: Alzheimer's disease; meeting /conference /symposium; neuropeptides; travel

DESCRIPTION (Provided by applicant): On behalf of the American Summer Neuropeptide Conference, request is being made from the National Institute on Aging to sponsor the symposium titled A1zheimer's Disease to be held as a part of NEUROPEPTIDES 2001, the 2nd Joint Meeting of the European Neuropeptide Club and the Summer Neuropeptide Conference. This joint international meeting will be held in Jerusalem and Tel Aviv, Israel, from May 7-12, 2001. The goal of the symposium is to bring together leaders in the fields of peptides and aging disorders research to discuss their latest findings on the relationship of neuropeptides to Alzheimer's disease. This symposium will provide important, timely information to aid in understanding the pathophysiology and neurochemical basis of Alzheimer's disease. Neuropeptide-related topics will range from basic molecular mechanisms to potential therapeutics of neuropeptides in the treatment of the debilitating aging disorder. Specifically, we are requesting funds for meeting expenses for several invited speakers in this symposium, and for several graduate student/postdoctoral trainee travel awards, for a total request of $12,600. The Summer Neuropeptide Conference, now in its eleventh year, and its counterpart the European Neuropeptide Club, also in its eleventh year, have become the premier international meetings for neuropeptide research. The conferences highlight major new advances in neuropeptide research and attract a good mixture of senior and junior participants from academia and industry from throughout the world. Active participation by graduate and postdoctoral trainees, as well as by women and minority scientists, is strongly encouraged. The format of the present joint conference involves morning, afternoon and evening symposia, poster sessions, conference dinners, and special lectures by distinguished scientists. This format, coupled with the informal setting, provides an ideal forum for the exchange of current information and the development of new collaborations among the participants.

描述（由申请人提供）：代表美国之夏 神经肽会议，国家研究所提出要求 老龄化组织将赞助A1zheimer病研讨会作为其一部分 NEUROPEPTIDES 2001，欧洲神经肽俱乐部第二届联席会议 和夏季神经肽会议。此次联合国际会议将 于2001年5月7日至12日在以色列耶路撒冷和特拉维夫举行。 该研讨会旨在汇聚肽和衰老领域的领导者 疾病研究讨论他们关于以下关系的最新发现 神经肽可治疗阿尔茨海默病。 本次研讨会将提供重要的、 及时的信息有助于了解病理生理学和 阿尔茨海默病的神经化学基础。神经肽相关主题将 从基本分子机制到潜在的治疗方法 神经肽治疗衰弱性衰老疾病。 具体来说，我们正在申请资金用于几位受邀者的会议费用 本次研讨会的演讲者以及几位研究生/博士后 实习生旅行奖励，总请求额为 12,600 美元。 夏季神经肽会议现已进入第十一个年头，其 对应的欧洲神经肽俱乐部也已进入第十一个年头， 成为神经肽研究的首要国际会议。这 会议强调神经肽研究的重大新进展并吸引 来自学术界和工业界的高级和初级参与者的良好组合 来自世界各地。研究生和博士后积极参与 强烈鼓励受训人员以及妇女和少数族裔科学家。 本次联席会议的形式分为上午、下午和 晚间研讨会、海报会议、会议晚宴和特别讲座 杰出的科学家。 这种形式，加上非正式的场合， 提供了一个理想的论坛来交流当前信息和 参与者之间发展新的合作。